These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Twenty-year follow-up of 160 patients with ataxia-telangiectasia. Ersoy F; Berkel AI; Sanal O; Oktay H Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037 [TBL] [Abstract][Full Text] [Related]
43. Plasma levels of carcinoembryonic antigen in patients with ataxia-telangiectasia. Sugimoto T; Sawada T; Tozawa M; Kidowaki T; Kusunoki T; Yamaguchi N J Pediatr; 1978 Mar; 92(3):436-9. PubMed ID: 75968 [No Abstract] [Full Text] [Related]
44. [Ataxia-telangiectasia surveyed in Sweden]. Lähdesmäki A; Arinbjarnarson K; Arvidsson J; el Segaier M; Fasth A; Fernell E; Gustafsson D; Oxelius VA; Risberg K; Yuen J; Zetterlund P; von Zweigbergk M; Ahsgren I; Hammarström L Lakartidningen; 2000 Oct; 97(40):4461-5, 4467. PubMed ID: 11068401 [TBL] [Abstract][Full Text] [Related]
45. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Moin M; Aghamohammadi A; Kouhi A; Tavassoli S; Rezaei N; Ghaffari SR; Gharagozlou M; Movahedi M; Purpak Z; Mirsaeid Ghazi B; Mahmoudi M; Farhoudi A Pediatr Neurol; 2007 Jul; 37(1):21-8. PubMed ID: 17628218 [TBL] [Abstract][Full Text] [Related]
46. Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida. Chandra RK Indian Pediatr; 1975 Jul; 12(7):545-8. PubMed ID: 52619 [No Abstract] [Full Text] [Related]
47. Speculations on the ataxia-telangiectasia defect. Gatti RA Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S10-5. PubMed ID: 1718644 [TBL] [Abstract][Full Text] [Related]
48. Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients. Chopra C; Davies G; Taylor M; Anderson M; Bainbridge S; Tighe P; McDermott EM Clin Exp Immunol; 2014 May; 176(2):275-82. PubMed ID: 24387201 [TBL] [Abstract][Full Text] [Related]
49. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature. Moeini Shad T; Yazdani R; Amirifar P; Delavari S; Heidarzadeh Arani M; Mahdaviani SA; Sadeghi-Shabestari M; Aghamohammadi A; Rezaei N; Abolhassani H Front Immunol; 2021; 12():779502. PubMed ID: 35095854 [TBL] [Abstract][Full Text] [Related]
50. [From gene to disease; ataxia telangiectasia]. Broeks A; van 't Veer LJ; Ottenheim C; Hiel JA; Kleijer WJ; Weemaes C Ned Tijdschr Geneeskd; 2003 Mar; 147(9):386-9. PubMed ID: 12661456 [TBL] [Abstract][Full Text] [Related]
51. Hereditary persistence of alpha-fetoprotein. van Deuren M; Verhagen M; Weemeas C Neth J Med; 2011 Feb; 69(2):96. PubMed ID: 21411851 [No Abstract] [Full Text] [Related]
52. Ataxia telangiectasia presenting as an extrapyramidal movement disorder and ocular motor apraxia without overt telangiectasia. Churchyard A; Stell R; Mastaglia FL Clin Exp Neurol; 1991; 28():90-6. PubMed ID: 1726561 [TBL] [Abstract][Full Text] [Related]
56. Ataxia-telangiectasia: an overview. Boder E Kroc Found Ser; 1985; 19():1-63. PubMed ID: 2415689 [TBL] [Abstract][Full Text] [Related]
57. Dysgerminoma in a child with ataxia-telangiectasia. Koksal Y; Caliskan U; Ucar C; Yurtcu M; Artac H; Ilerisoy-Yakut Z; Reisli I Pediatr Hematol Oncol; 2007 Sep; 24(6):431-6. PubMed ID: 17710660 [TBL] [Abstract][Full Text] [Related]
58. Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver. Ohama E; Ikuta F Acta Neuropathol; 1982; 56(1):13-6. PubMed ID: 6175161 [No Abstract] [Full Text] [Related]
59. Candidates for the molecular defect in ataxia telangiectasia. Gatti RA Adv Neurol; 1993; 61():127-32. PubMed ID: 7678481 [No Abstract] [Full Text] [Related]
60. Atypical lymphoid leukemia in ataxia telangiectasia. Levitt R; Pierre RV; White WL; Siekert RG Blood; 1978 Nov; 52(5):1003-11. PubMed ID: 698387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]